Error 2: using the wrong concentration A patient has been using a 2.5 mg/mL vial and drawing 10 units (0.25 mg) weekly
GLP-1 receptor agonists are peptide-based biologics that are absorbed directly into the systemic circulation from subcutaneous tissue, making them independent of intestinal absorption processes that might be affected by altered bile flow
9 Globally, the market for GLP-1s reached $50 billion in 2024, with projections to more than double by 2030 10 and already millions of Americans are prescribed the treatment
This means that not all cardiovascular benefits are lost
A well-structured program provides clarity, measurable outcomes, and ongoing guidance throughout
If you have a history of B12 deficiency, malabsorption issues, or are vegetarian/vegan with marginal B12 status, the weekly B12 injection provides protection during the high-risk period of rapid weight loss